Latest Regulatory Change News

Bridge SaaS Limited (ASX: BGE) is issuing nearly 20 million Loyalty Options to reward shareholders, exercisable at $0.03 and expiring in 2031, aiming to bolster future capital without immediate dilution.

The Therapeutic Goods Administration has broadened the range of clinicians eligible to participate in psychedelic-assisted psychotherapy, a move set to speed up recruitment and improve patient access across Emyria’s national Empax network.

Metro Performance Glass has significantly improved its financial footing in FY26, cutting net debt by more than half and boosting EBITDA before significant items to $18.2 million despite subdued markets in New Zealand and Australia.

Ainsworth Game Technology posted a 10% revenue increase in FY25 to $291 million, driven by strong Asia Pacific growth, while North American challenges weigh on H1 2026 outlook.

Vodafone Group Plc’s 2026 Annual Report reveals a transformative year marked by the full consolidation of VodafoneThree UK after a landmark merger, acquisition of Telekom Romania and Skaylink, and a planned controlling stake in Safaricom. The Group achieved strong financial results, increased dividends, and reinforced ESG commitments across Europe and Africa.

SDI Limited has dispatched its Scheme Booklet to shareholders as it moves closer to a $1.40 per share acquisition by a Beijing Guoci subsidiary. The virtual shareholder meeting is set for 22 June 2026 with strong backing from the board and largest shareholder.

Connexion Mobility Ltd has agreed to acquire Hallam Road Automotive in a A$5 million deal expected to immediately lift earnings per share by up to 35% and reduce exposure to foreign exchange fluctuations.

Nationwide Building Society reported a 9% rise in underlying profit to £2.026 billion for FY26, driven by market-leading mortgage growth and successful Virgin Money integration, while maintaining robust capital and liquidity positions.

SDI Limited's acquisition by Beijing Guoci's subsidiary advances with ASIC registration of the scheme booklet and court approval to convene a shareholder meeting. The all-cash offer at a 53–58% premium awaits shareholder and final court approval.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.

EDU Holdings delivered a transformational FY25 with nearly doubled revenue and a debt-free balance sheet, driven by strong growth in its higher education arm Ikon. The company started FY26 on a solid footing despite regulatory headwinds.

Westpac Banking Corporation posted a statutory net profit of AUD 3.414 billion for the half year ended March 2026, marking a 3% increase on the prior corresponding period despite a 5% decline from the previous half. The bank maintained a strong capital position and declared a fully franked interim dividend of 77 cents per share.